Patients | Renal Function | Mode of Dialytic Therapy | Initial Blood Pb Level | Post-dialysis Blood Pb Level | Dialytic Pb Removal | Urinary Pb Excretion | Outcome |
---|---|---|---|---|---|---|---|
1 – Smith [37] | Normal | HD - 2 h | 3.1 mg/g | 1.0 mg/g | 3.4 mg | n/a | Died |
2 | Normal | HD - 2 h | 2.7 mg/g | 1.3 mg/g | 3.0 mg | n/a | Improved encephalopathy |
3 | Normal | HD - 30 min | 1.6 mg/g | 1.1 mg/g | 1.0 mg | n/a | Remained severely encephalopathic |
4 | Normal | HD - 2 h | 1.8 mg/g | 0.7 mg/g | 2.2 mg | n/a | Died |
1 – Mehbod [38] | GFR < 10 | CAPD | n/a | n/a | 16.9 mg/20 h | 0.12 mg/20 h | Weakness; constipation and anaemia improved |
2 | Normal | CAPD | n/a | n/a | 1.90 mg/20 h | 0.50 mg/20 h | No immediate improvement; no long-term follow up |
3 | Normal | CAPD | n/a | n/a | 1.48 mg/20 h | 0.70 mg/20 h | No immediate improvement; no long-term follow up |
4 | Normal | CAPD | 1.25 mg/L | 0.75 mg/L | 2.00 mg/20 h | 0.40 mg/20 h | Improved encephalopathy; no long-term follow up |
1 – Pedersen [39] | Normal | HD – 9 h | 1.36 mg/L | 0.68 mg/L | n/a | n/a | Serum Pb level 0.28 mg/L after 7 weeks; no clinical outcome reported |
1 – Roger [40] | ESKF | CAPD | 1.40 μmol/L | n/a | 9.29 μmol over 4 days | 2.96 μmol/day on day 4 | Improved mental state but peripheral neuropathy progressed after 4 months |
1 – Kessler [41] | ESKF | HF | 0.279 mg/L | n/a | 1.650 mg/day a | n/a | |
2 | ESKF | HF | 0.131 mg/L | n/a | 1.450 mg/day a | n/a | |
3 | ESKF | HF | 0.361 mg/L | n/a | 1.152 mg/day a | Died | |
4 | ESKF | HF | 0.281 mg/L | n/a | 1.267 mg/day a | n/a | |
5 | ESKF | CAPD | 0.265 mg/L | n/a | 0.334 mg/day | 0.476 mg/day | n/a |
1 – Kessler [42] | ESKF | HF | 0.280 mg/L | n/a | 3.300 mg/day a | n/a | |
2 | ESKF | CAPD | 0.265 mg/L | n/a | 0.710 mg/day a | n/a | |
1 – Barats [43] | ESKF | HD | 0.690 mg/L | 0.110 mg/Lb | n/a | n/a | Resolved encephalopathy and motor neuropathy |
1 – Roberts [44] | ESKF | HD | 0.49 μg/L | n/a | 0.24 mg | 0.025 mg | Lead mobilisation test |